Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TScan Therapeutics, Inc. | 350,000 | reported | 20 Jan 2026 | tx 18+1,564,402−321,872 |
| Dianthus Therapeutics, Inc. /DE/ | 67,700 | reported | 11 Feb 2021 | tx 15+217,344−41,167 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jan 2026 | GRANT_AWARD | TScan Therapeutics, Inc. | 350,000 | 0.00 USD | deriv |
| 12 Jan 2024 | GRANT_AWARD | TScan Therapeutics, Inc. | 52,500 | 0.00 USD | deriv |
| 03 Jan 2025 | GRANT_AWARD | TScan Therapeutics, Inc. | 250,000 | 0.00 USD | deriv |
| 23 Aug 2024 | SALE | TScan Therapeutics, Inc. | 164,686 | 5.78 USD | |
| 23 Aug 2024 | EXERCISE | TScan Therapeutics, Inc. | 64,166 | 2.49 USD | |
| 23 Aug 2024 | EXERCISE | TScan Therapeutics, Inc. | 13,125 | 1.81 USD | |
| 23 Aug 2024 | EXERCISE | TScan Therapeutics, Inc. | 25,000 | 3.27 USD | |
| 23 Aug 2024 | EXERCISE | TScan Therapeutics, Inc. | 54,895 | 4.85 USD | |
| 23 Aug 2024 | EXERCISE | TScan Therapeutics, Inc. | 64,166 | 0.00 USD | deriv |
| 23 Aug 2024 | EXERCISE | TScan Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 23 Aug 2024 | EXERCISE | TScan Therapeutics, Inc. | 54,895 | 0.00 USD | deriv |
| 23 Aug 2024 | EXERCISE | TScan Therapeutics, Inc. | 13,125 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | TScan Therapeutics, Inc. | 430,000 | 0.00 USD | deriv |
| 02 Feb 2023 | GRANT_AWARD | TScan Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 25 Jul 2022 | GRANT_AWARD | TScan Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 18 Jan 2022 | GRANT_AWARD | TScan Therapeutics, Inc. | 85,000 | 0.00 USD | deriv |
| 23 Sept 2021 | PURCHASE | TScan Therapeutics, Inc. | 4,716 | 7.48 USD | |
| 07 Sept 2021 | GRANT_AWARD | TScan Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 11 Feb 2021 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 67,700 | 0.00 USD | deriv |
| 10 Feb 2020 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 60,000 | 0.00 USD | deriv |
| 23 Dec 2019 | SALE | Dianthus Therapeutics, Inc. /DE/ | 4,181 | 16.03 USD | |
| 24 Dec 2019 | SALE | Dianthus Therapeutics, Inc. /DE/ | 7,902 | 16.00 USD | |
| 05 Feb 2019 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 80,000 | 0.00 USD | deriv |
| 25 Jun 2018 | CONVERSION | Dianthus Therapeutics, Inc. /DE/ | 4,643 | — | |
| 25 Jun 2018 | CONVERSION | Dianthus Therapeutics, Inc. /DE/ | 12,000 | — | deriv |